| Literature DB >> 35047392 |
Zijun Guo1, Lingjun Meng1, Shuxin Tian1,2, Lan Chen3, Huiying Shi1, Mengke Fan1, Rong Lin1.
Abstract
BACKGROUND: Lugol chromoendoscopy (LCE) is a technique that is inexpensive and convenient for screening esophageal neoplastic lesions. However, the specificity of LCE is limited. The purpose of this study was to determine the risk characteristics of lesions related to false-positive results for LCE.Entities:
Keywords: Lugol chromoendoscopy; esophageal neoplasia; esophageal squamous cell carcinoma; misdiagnosis; risk factors
Year: 2022 PMID: 35047392 PMCID: PMC8763246 DOI: 10.3389/fonc.2021.763375
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244
Figure 1The staining patterns of Lugol chromoendoscopy (LCE) were graded and classified into four types. (A) Unstained; (B) understained, less intense staining; (C) normal greenish-brown staining; (D) hyperstaining.
Figure 2Representative pictures of pathological classification. (A) Negative for neoplasia/dysplasia (including normal, reactive, regenerative, hyperplastic, atrophic, and metaplastic epithelium); (B) noninvasive low-grade neoplasia; (C) noninvasive high-grade neoplasia; (D) invasive neoplasia.
Figure 3Representative pictures of specific endoscopic characteristics. (A) Disorder, disappearance, or truncation of the vascular network; (B) nodule, lesions with a diameter of less than 1 cm, bulging surface, and rough/erosive mucosa; (C) plaque, massive lesions that are mostly white and slightly raised from the mucosal surface with clear borders; (D) speckled esophagus, multiple Lugol-unstained speckles were present throughout the esophagus.
Biopsy results displayed based on LCE results (number of lesions).
| Neoplastic* | Non-neoplastic | Total | |
|---|---|---|---|
| LCE positive | 269 | 358 | 627 |
| LCE negative | 0 | 244 | 244 |
| Total | 269 | 602 | 871 |
LCE, Lugol chromoendoscopy.
*Includes low-grade intraepithelial neoplasia (LGIN), high-grade intraepithelial neoplasia (HGIN), and invasive/advanced carcinoma.
Diagnostic performance of LCE for esophageal neoplastic lesions.
| Diagnostic performance | Value |
|---|---|
| Sensitivity*(95% CI) (%) | 100.0 (98.2–100) |
| Specificity*(95% CI) (%) | 40.5 (36.6–44.6) |
| PPV (95% CI) (%) | 42.9 (39.0–46.9) |
| NPV (95% CI) (%) | 100.0 (98.1–100.0) |
| Accuracy*(95% CI) (%) | 58.9 (55.6–62.1) |
LCE, Lugol chromoendoscopy.
*McNemar’s test was used to assess sensitivity, specificity, and accuracy.
Multivariate logistic regression analysis of risk factors for misdiagnosis by LCE.
| No. of lesions | No. of misdiagnosed lesions | OR | 95% CI |
| |
|---|---|---|---|---|---|
|
| |||||
| <5 | 193 | 156 | 3.06 | 1.38–6.78 | 0.006 |
| 5–10 | 178 | 88 | 0.91 | 0.43–1.95 | 0.808 |
| 11–30 | 166 | 73 | 2.21 | 0.97–5.01 | 0.059 |
| >30 | 90 | 41 | 1 | Reference | |
|
| |||||
| Branching vascular network | 479 | 312 | 4.53 | 2.23–9.21 | <0.001 |
| Disappeared vascular network | 148 | 46 | 1 | Reference | |
|
| |||||
| Smooth | 193 | 151 | 2.40 | 1.38–4.18 | 0.002 |
| Rough | 434 | 207 | 1 | Reference | |
|
| |||||
| Ill-demarcated | 327 | 266 | 7.83 | 4.59–13.37 | <0.001 |
| Well-demarcated | 300 | 92 | 1 | Reference | |
|
| |||||
| PCS negative | 295 | 318 | 4.04 | 2.38–6.84 | <0.001 |
| PCS positive | 424 | 40 | 1 | Reference |
LCE, Lugol chromoendoscopy; PCS, Pink color sign.
*The margin of lesions under Lugol chromoendoscopy.